Key facts
- Ufonia’s last known valuation is $17.7M (Sep 2022).
- It has raised $4.4M.
- Notable investors include Innovate UK, Octopus Ventures, Charles Songhurst, Mark Evans, Science & Technology Facilities Council — 17 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Ufonia
- ·The full record, as it builds
Funding rounds
No funding rounds for Ufonia are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ufonia
Developer of an AI-driven voice technology designed to replace routine patient healthcare interactions with automated phone calls. The company's technology offers autonomous, automated, telephone-based clinical follow-up for capturing patient-reported outcome measures, enabling healthcare organizations to monitor health and wellness through a conversational voice bot.
- Sector
- Information Technology
- HQ
- Oxford, United Kingdom
- Founded
- 2017
- Employees
- 40
- Website
- ufonia.com/
- Ownership
- Privately Held (backing)
Ufonia doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ufonia shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ufonia in its N-PORT filings yet. We sweep new filings monthly.